Maine Medicine Weekly Update - 12/16/2019  (Plain Text Version)

Return to Graphical Version


In this issue:
•  Walmart Will Delay Electronic Prescribing Mandate
•  U.S. CDC: At Least 1,300 Deaths from Flu This Season...So Far
•  Schmidt Institute Opioid Program Expands Statewide
•  Opioid Related Webinars Offer CME Credit
•  This Week's Public Health Updates from the AMA
•  Resources From The Alzheimer's Association
•  MMA Legislative Calls Will Begin Tuesday, January 14th
•  Maine Legislature's List of Bill Titles for 2020 Session: Initial Approval List
•  Upcoming Specialty Society Meetings
•  MMA partners with the Maine Suicide Prevention Program and the Maine CDC/Sweetser to offer training for clinicians.
•  10th Annual Maine Patient Safety Academy - March 30, 2020
•  Orthopedic Surgeon Opportunity in Beautiful New England
•  Northern Light Sebasticook Valley Hospital seeks a BC/BE General Surgeon
•  Family Medicine Physician
•  Family Medicine Opportunity in Beautiful Western Maine
•  BC/BE Family Medicine or Internal Medicine Physician
•  Opportunities at the VA for Volunteer Physicians
•  Volunteer Opportunity with Partners for World Health - Portland, ME


Schmidt Institute Opioid Program Expands Statewide

A successful opioid and benzodiazepine prevention program sponsored by the Maine Office of Substance Abuse and Mentail Health Services and the Schmidt Institute, a joint venture of St. Joseph's Hospital and Penobscot Community Health Center, is being expanded statewide.


[from the Maine Hospital Association's Friday Report]

A program that that has reduced patient dependence on opioids and benzodiazepines in the Bangor area is being expanded statewide through a partnership between the Maine Office of Substance Abuse and Mental Health Services (SAHMS) and the Schmidt Institute, a joint venture of St. Joseph Healthcare and Penobscot Community Health Care (PCHC).

Since 2013, the Institute’s Controlled Substance Stewardship (CSS) Program has been implemented at PCHC, a Federally Qualified Health Center that serves 65,000 patients.  This effort has resulted in a 77 percent reduction in overall opioid and benzodiazepine prescribing at PCHC’s practice sites, a key effort given that opioids put patients at great risk for unintentional overdose and have not been proven effective as a long-term treatment for chronic pain.

CSS provides support and consultation to prescribing clinicians with a goal of promoting compassionate, coordinated care for patients whose prescriptions are being tapered.  It also offers tools for clinicians and practice staff, such as informed consent and patient-provider agreements that provide clear descriptions of risks and expectations of treatment, and prompt referral and access to experts in alternative pain management and other relevant services (e.g., medication-assisted treatment for Opioid Use Disorder).

The program supports front-line providers who are caring for patients with chronic pain, substance use disorders, mental illness and other complex conditions.  CSS disseminates to providers clear and practical policies around evidence-based prescribing and management of opioids, benzodiazepines, hypnotics and stimulants.

SAMHS, an office of the Maine Department of Health and Human Services, is sponsoring a statewide expansion of the model, with the goal of promoting safer, evidence-based treatment options for chronic pain, while supporting providers in alleviating opioid prescribing issues and concerns.

The partnership will include establishing statewide prescribing guidelines that providers and organizations can use to inform their opioid prescribing and tapering practices, and clinical case reviews by the Institute’s CSS Committee, an interdisciplinary team with expertise in pharmacy, pain management, family medicine, psychiatry and care management.

Case reviews will be offered at no cost to providers in Maine, thanks in part to financial support from the state of Maine through Overdose Data to Action, a federal Centers for Disease Control and Prevention grant recently awarded to the state.

For more information about the Schmidt Institute and their CSS work, contact:  Larry Clifford, director, planning & development, Schmidt Institute, (207) 404-8032.